Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:I-246-I-252
doi: 10.1161/hc37t1.094712
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smolenski, R. T.
Right arrow Articles by Yacoub, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smolenski, R. T.
Right arrow Articles by Yacoub, M. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
*Heart Transplantation
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Energy metabolism
Right arrow Ischemic biology - basic studies
Right arrow Anticoagulant mechanisms
Right arrow Transplantation
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2001;104:I-246.)
© 2001 American Heart Association, Inc.


Thoracic Transplantation and Ventricular Assist Devices

Protection From Reperfusion Injury After Cardiac Transplantation by Inhibition of Adenosine Metabolism and Nucleotide Precursor Supply

Ryszard T. Smolenski, MD, PhD; Olivier Raisky, MD; Ewa M. Slominska, PhD; Haitham Abunasra, MD; Kameljit K. Kalsi, PhD; Jay Jayakumar, MD; Ken Suzuki, MD, PhD; Magdi H. Yacoub, DSc, FRS

Heart Science Centre (R.T.S., O.R., H.A., K.K.K., J.J., K.S., M.H.Y.), Imperial College School of Medicine at Harefield Hospital, Harefield, Middlesex, UK; and Department of Biochemistry (R.T.S., E.M.S.), Medical University of Gdansk, Gdansk, Poland.

Correspondence to Dr Ryszard T. Smolenski, Heart Science Centre, Imperial College School of Medicine at Harefield Hospital, Harefield, Middlesex UB9 6JH, UK. E-mail r.smolenski{at}ic.ac.uk

Background— Adenosine (Ado) triggers numerous protective mechanisms in the heart that may attenuate ischemia-reperfusion injury in cardiac grafts. We aimed to establish whether sustained increase in endogenous Ado production by the combined application of Ado metabolism inhibitors and nucleotide precursors attenuates reperfusion injury in transplanted hearts.

Methods and Results— Rat hearts were collected after the infusion of St Thomas’ Hospital cardioplegic solution, stored at 4°C for 4 hours, and heterotopically transplanted into the abdomen of recipient rats. A solution containing Ado deaminase inhibitor erythro-9(2-hydroxy-3-nonyl)adenine, Ado kinase inhibitor 5'-aminoadenosine, and nucleotide precursors adenine and ribose was administered at the time of reperfusion in the treated group, whereas saline was administered to control animals. After 1 or 24 hours, mechanical function of the transplanted hearts was evaluated in an ex vivo perfusion system followed by the determination of myocardial ATP with related metabolites and measurement of the activity of neutrophil-specific enzyme myeloperoxidase in cardiac homogenates. After 24 hours of reperfusion, maximum left ventricular developed pressure increased from 87.0±6.8 mm Hg (mean±SEM) in controls to 118.1±8.2 mm Hg in the treated group (P<0.05), ATP increased from 11.0±0.8 µmol/g dry wt in controls to 15.1±1.2 µmol/g dry wt in the treated group (P<0.01), and myeloperoxidase activity decreased from 2.23±0.60 U/g wet wt in controls to 0.58±0.12 U/g wet wt in the treated group (P<0.001). No differences in cardiac function, ATP, or myeloperoxidase activity were observed between the treated group and controls after 1 hour of reperfusion.

Conclusions— The administration of Ado metabolism inhibitors with nucleotide precursors causes a sustained increase in endogenous Ado production and exerts a potent protective effect against reperfusion injury in transplanted hearts. Improved cardiac function and elevated ATP concentration were accompanied by complete amelioration of neutrophil infiltration in treated hearts, suggesting that reduction in postischemic inflammation could be an important mechanism of this protective effect.


Key Words: adenosine • transplantation • reperfusion • inflammation • leukocytes